Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹24 Cr
Revenue (TTM)
₹125 Cr
Net Profit (TTM)
₹1 Cr
ROE
2.6 %
ROCE
7 %
P/E Ratio
24.3
P/B Ratio
0.6
Industry P/E
35.17
EV/EBITDA
10.3
Div. Yield
0 %
Debt to Equity
0.4
Book Value
₹16
EPS
₹0.4
Face value
10
Shares outstanding
26,289,250
CFO
₹-38.33 Cr
EBITDA
₹13.80 Cr
Net Profit
₹4.31 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dipna Pharmachem
| -46.7 | -0.4 | -46.7 | -35.7 | -4.4 | -- | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Dipna Pharmachem
| 15.8 | 60.5 | -47.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dipna Pharmachem
|
9.0 | 23.7 | 124.9 | 1.0 | -- | 2.6 | 24.3 | 0.6 |
| 2,110.2 | 17,282.6 | 1,215.1 | 284.8 | 28.7 | 21.1 | 60.2 | 11.4 | |
| 656.2 | 12,893.6 | 7,266.8 | 627.5 | 11.9 | 12.6 | 20.5 | 2.4 | |
| 613.6 | 15,214.7 | 5,092.5 | 545.5 | 15.9 | 14.1 | 27.9 | 3.7 | |
| 839.3 | 13,375.6 | 7,918.4 | 429.9 | 10.7 | 7.2 | 30.9 | 2.0 | |
| 1,027.6 | 18,409.8 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11.8 | 2.1 | |
| 1,404.5 | 16,092.2 | 1,419.3 | 20.1 | 8.4 | 0.5 | 800.5 | 2.8 | |
| 142.2 | 18,882.0 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.4 | |
| 391.1 | 15,752.9 | 3,720.2 | 352.1 | 13.7 | 8.2 | 44.7 | 3.3 | |
| 1,271.5 | 20,670.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 939.6 | 4.5 |
No Review & Analysis are available.
Trading,exporting,importing of chemicals
Incorporated
2011
Chairman
--
Managing Director
Keyur Shah
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Dipna Pharmachem Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsClarification sought from Dipna Pharmachem Ltd
23-Feb-2026Clarification sought from Dipna Pharmachem Ltd
14-Jan-2026Statement Of Deviation And Variation
26-Nov-2025
The share price of Dipna Pharmachem Ltd is ₹9.00 (BSE) as of 02-Apr-2026 IST. Dipna Pharmachem Ltd has given a return of -4.43% in the last 3 years.
The P/E ratio of Dipna Pharmachem Ltd is 24.29 times as on 02-Apr-2026, a 31 discount to its peers’ median range of 35.17 times.
The P/B ratio of Dipna Pharmachem Ltd is 0.57 times as on 02-Apr-2026, a 82 discount to its peers’ median range of 3.21 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
35.30
|
0.89
|
|
2024
|
20.87
|
0.60
|
|
2023
|
13.54
|
0.62
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Dipna Pharmachem Ltd are Rs 26.31 and Rs 7.45 as of 03-Apr-2026.
Dipna Pharmachem Ltd has a market capitalisation of ₹ 24 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Dipna Pharmachem Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.25
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.